Thursday, August 03, 2017 9:29:07 AM
CFGX - Volume dried-up, over the last 30-days !
http://www.investorpoint.com/stock/CFGX-CAPITAL+FINCL+GLOBAL+INC/price-history/
CFGX Security Details
Share Structure
Market Value1...........$178,628 a/o Aug 02, 2017
Authorized Shares..2,850,000,000 a/o Jul 31, 2017
Outstanding Shares 1,786,275,316 a/o Jul 31, 2017
Float..............1,704,830,294 a/o Jul 08, 2017
Par Value 0.001
http://www.otcmarkets.com/stock/CFGX/profile
_________________________________________________________________
* The Thinner, The Better !
_________________________________________________________________
How Share Structure Enables a Stock to Move
________________________________________________________________
_________________________________________________________________
We Select The Very BEST Bottom Plays!
The Very BEST Bottom Plays have Great Tops!
* We'll Always Promote Stocks Based On Their Bottom Formation !
* We'll Always Promote Stocks Based On Their Share Structure !
_________________________________________________________________
Buy after an Elliott Wave 5-Wave Decline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133040947
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131958679
Educational Post: The Planned Trade
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133214060
________________________________________________________________
Our Picks are Ripe, and Ready to Go !
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133213093&txt2find=ICNB
________________________________________________________________
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
Live! Charts
CFGX - Targets 0.0007 / 0.0012 / 0.0015 / 0.0018 / 0.0030
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM